BCL2 and cancer: Herein, we observed that gAcrp inhibited Bcl‐2 expression in HepG2 cells (Fig. 1E–H), which is accompanied with induction of caspase‐3 activity (Fig. 1C,D), suggesting that gAcrp induces apoptotic cell death triggered by suppression of Bcl‐2 in cancer cells.